2025-06-13 |
13D/A |
HCWB / HCW Biologics Inc. |
Wong Hing C |
501,911 |
23.38 |
-96.87 |
2025-06-13 |
13D/A |
HYPD / Hyperion DeFi, Inc. |
Avenue Venture Opportunities Fund, L.P. |
435,438 |
9.99 |
-92.72 |
2025-06-12 |
13D/A |
SLGL / Sol-Gel Technologies Ltd. |
Arkin Moshe |
1,950,113 |
65.31 |
|
2025-06-11 |
13D/A |
ERNA / Ernexa Therapeutics Inc. |
Cherington Charles |
41,690,775 |
37.90 |
104.04 |
2025-06-10 |
13D/A |
ENTO / Entero Therapeutics, Inc. |
Ali Arif Nasir |
230,900 |
4.90 |
-7.97 |
2025-06-09 |
13D |
ENTO / Entero Therapeutics, Inc. |
Ali Arif Nasir |
250,900 |
5.30 |
|
2025-06-09 |
13D/A |
URGN / UroGen Pharma Ltd. |
Monograph Capital Partners I, L.P. |
838,615 |
1.90 |
|
2025-06-09 |
13D/A |
RFL / Rafael Holdings, Inc. |
Jonas Howard S |
14,688,994 |
28.40 |
|
2025-06-09 |
13D/A |
RFL / Rafael Holdings, Inc. |
i9 PLUS, LLC |
3,616,431 |
7.00 |
8.33 |
2025-06-09 |
13D/A |
AYTU / Aytu BioPharma, Inc. |
Nantahala Capital Management, LLC |
1,086,812 |
14.40 |
0.00 |
2025-06-09 |
13D/A |
NATR / Nature's Sunshine Products, Inc. |
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. |
2,918,774 |
15.90 |
2.25 |
2025-06-06 |
13D/A |
ANIX / Anixa Biosciences, Inc. |
Kumar Amit |
6,173,097 |
16.30 |
9.19 |
2025-06-06 |
13D/A |
TYRA / Tyra Biosciences, Inc. |
Ra Capital Management, L.p. |
11,899,788 |
22.40 |
11.37 |
2025-06-06 |
13D/A |
STOK / Stoke Therapeutics, Inc. |
Blue Horizon Enterprise Ltd |
3,906,181 |
7.20 |
|
2025-06-05 |
13D |
ORIC / ORIC Pharmaceuticals, Inc. |
Sr One Capital Management, Llc |
4,615,384 |
5.40 |
|
2025-06-04 |
13D/A |
ELTX / Elicio Therapeutics, Inc. |
Gkcc, Llc |
9,764,864 |
48.00 |
74.53 |
2025-06-04 |
13D |
NBY / NovaBay Pharmaceuticals, Inc. |
Poplar Point Capital Management Llc |
1,020,300 |
17.54 |
5.01 |
2025-06-03 |
13D/A |
HYPD / Hyperion DeFi, Inc. |
Avenue Venture Opportunities Fund, L.P. |
5,982,998 |
9.99 |
0.00 |
2025-06-03 |
13D/A |
PAHC / Phibro Animal Health Corporation |
BFI Co., LLC |
20,225,514 |
49.90 |
0.00 |
2025-06-03 |
13D |
ABVC / ABVC BioPharma, Inc. |
Eugene Jiang |
131,159 |
17.40 |
|
2025-05-30 |
13D/A |
OKUR / OnKure Therapeutics, Inc. |
Acorn Bioventures, L.p. |
2,839,674 |
22.10 |
0.00 |
2025-05-29 |
13D/A |
PRTA / Prothena Corporation plc |
EcoR1 Capital, LLC |
0 |
0.00 |
-100.00 |
2025-05-28 |
13D |
PRQR / ProQR Therapeutics N.V. |
Van Herk Investments B.v. |
11,501,995 |
10.90 |
0.35 |
2025-05-27 |
13D/A |
BGM / BGM Group Ltd. |
AIX Inc. |
16,529,330 |
8.99 |
-76.39 |
2025-05-27 |
13D |
BGM / BGM Group Ltd. |
Low Thia Yang |
38,165,290 |
20.70 |
|
2025-05-23 |
13D |
RPRX / Royalty Pharma plc |
Legorreta G. Pablo |
103,112,796 |
19.74 |
|
2025-05-22 |
13D |
OKUR / OnKure Therapeutics, Inc. |
Acorn Bioventures, L.p. |
2,839,674 |
22.10 |
97.24 |
2025-05-22 |
13D/A |
INDV / Indivior PLC |
Two Seas Capital LP |
11,880,926 |
9.50 |
2.60 |
2025-05-21 |
13D/A |
BHC / Bausch Health Companies Inc. |
Paulson & Co. Inc. |
26,439,035 |
7.10 |
2.32 |
2025-05-21 |
13D/A |
BHC / Bausch Health Companies Inc. |
Icahn Partners Master Fund LP |
34,721,118 |
9.40 |
|
2025-05-20 |
13D/A |
MTVA / MetaVia Inc. |
Dong-a St Co., Ltd |
9,995,679 |
51.10 |
-14.63 |
2025-05-20 |
13D/A |
XOMA / XOMA Royalty Corporation |
Biotechnology Value Fund L P |
2,590,303 |
21.60 |
-13.17 |
2025-05-19 |
13D/A |
GLPG / Galapagos NV - Depositary Receipt (Common Stock) |
EcoR1 Capital, LLC |
7,803,202 |
11.84 |
10.00 |
2025-05-15 |
13D |
HYPD / Hyperion DeFi, Inc. |
Avenue Venture Opportunities Fund, L.P. |
5,982,998 |
67.90 |
|
2025-05-14 |
13D/A |
CRVS / Corvus Pharmaceuticals, Inc. |
Orbimed Advisors Llc |
9,785,423 |
12.20 |
0.00 |
2025-05-14 |
13D/A |
HOWL / Werewolf Therapeutics, Inc. |
Ra Capital Management, L.p. |
6,746,807 |
15.00 |
8.94 |
2025-05-14 |
13D/A |
BBIO / BridgeBio Pharma, Inc. |
KKR Genetic Disorder L.P. |
13,260,971 |
7.00 |
-31.15 |
2025-05-14 |
13D |
TCRT / Alaunos Therapeutics, Inc. |
Pmgc Capital Llc |
83,500 |
5.09 |
|
2025-05-13 |
13D/A |
OLMA / Olema Pharmaceuticals, Inc. |
Logos Global Management LP |
3,208,875 |
4.70 |
-1.23 |
2025-05-13 |
13D/A |
PHAT / Phathom Pharmaceuticals, Inc. |
Frazier Life Sciences Public Fund, L.P. |
14,429,990 |
19.90 |
12.83 |
2025-05-13 |
13D/A |
ONC / BeOne Medicines AG - Depositary Receipt (Common Stock) |
Hillhouse Capital Advisors, Ltd. |
68,551,141 |
4.90 |
-26.13 |
2025-05-12 |
13D/A |
EWTX / Edgewise Therapeutics, Inc. |
Orbimed Advisors Llc |
15,252,867 |
14.50 |
3.37 |
2025-05-12 |
13D/A |
KROS / Keros Therapeutics, Inc. |
ADAR1 Capital Management, LLC |
5,390,964 |
13.27 |
0.00 |
2025-05-09 |
13D/A |
OSTX / OS Therapies Incorporated |
Auerbach Shalom |
2,687,570 |
9.90 |
-5.02 |
2025-05-09 |
13D/A |
IVA / Inventiva S.A. - Depositary Receipt (Common Stock) |
Biotechnology Value Fund L P |
8,545,499 |
6.10 |
0.00 |
2025-05-08 |
13D/A |
KROS / Keros Therapeutics, Inc. |
ADAR1 Capital Management, LLC |
5,390,964 |
13.27 |
0.00 |
2025-05-08 |
13D/A |
SLNCF / Silence Therapeutics plc |
Griffiths Richard Ian |
32,912,599 |
23.20 |
6.40 |
2025-05-07 |
13D/A |
IVA / Inventiva S.A. - Depositary Receipt (Common Stock) |
New Enterprise Associates 17, L.P. |
8,350,730 |
6.00 |
6.57 |
2025-05-06 |
13D/A |
PRTA / Prothena Corporation plc |
EcoR1 Capital, LLC |
5,304,596 |
9.90 |
-54.21 |
2025-05-06 |
13D/A |
IRD / Opus Genetics, Inc. |
Foundation Fighting Blindness Retinal Degeneration Fund |
9,492,171 |
15.90 |
270.10 |